Table 3. Differences between plasma betaine quintiles.
p | Q1 | Q2 | Q3 | Q4 | Q5 | |
Pl betaine (µmol/L) | .. | 28.9 | 37.6 | 45.3 | 54.2 | 70.0 |
Age (years) | 0.46 | 66 | 68 | 68 | 68 | 70 |
BMI | 0.002 | 28.0 | 27.2 | 26.4 | 26.5 | 25.3 |
Left ventricular ejection fraction | 0.14 | 60 | 58 | 60 | 60 | 57 |
Pl creatinine (µmol/L) | 0.31 | 99 | 90 | 100 | 92 | 90 |
Pl urea (mmol/L) | 0.28 | 6.5 | 5.9 | 6.5 | 6.7 | 6.5 |
Pl homocysteine (µmol/L) | 0.12 | 13.5 | 12.3 | 12.6 | 12.5 | 12.3 |
Pl Non-HDL cholesterol (mmol/L) | <0.001 | 3.38 | 2.98 | 3.22 | 2.97 | 2.64 |
Pl NT-proBNP (pmol/L) | 0.002 | 71 | 46 | 45 | 71 | 101 |
With diabetes (%) | 0.18 | 15 | 24 | 18 | 17 | 11 |
Median data in subsets of study population based on quintiles of gender-adjusted plasma (pl) betaine concentrations from Q1 (lowest quintile) to Q5 (highest quintile), with significance (p) for difference between quintiles (Kruskal-Wallis one way analysis of variance on ranks). Significant (p<0.05) differences between quintiles marked in bold. “With diabetes” row shows percentage of subjects in each plasma betaine quintile who had diabetes.